Feasibility Trial of the Bios Device for Continuous Glucose Monitoring
- Conditions
- Type 1 DiabetesType 2 Diabetes
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- GraphWear Technologies Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT04226846
- Locations
- 🇺🇸
Diablo Clinical Research, Inc, Walnut Creek, California, United States
© Copyright 2025. All Rights Reserved by MedPath